$CRVS

$10.50▲ -0.4% YTD

6 SEC 13D/G filings tracked · Last updated Oct 29, 2026

Filing History

News

CRVS ▼ -0.4% - Corvus Pharmaceuticals, Inc.

CP $10.50▲ -0.4%Oct 29, 2026 · ThinkSabio Blog

$CRVS - Corvus Pharmaceuticals to Provide Business Update and Third Quarter 2026 Financial Results on November 5, 2026…

News

CRVS ▼ -0.5% - Corvus Pharmaceuticals, Inc.

CP $11.70▲ -0.5%Sep 30, 2026 · ThinkSabio Blog

$CRVS - Corvus Pharmaceuticals Announces Initiation of Phase 1b Clinical Trial of Soquelitinib for Patients with Hidradenitis Suppurativa…

News

CRVS ▼ -0.3% - Corvus Pharmaceuticals, Inc.

CP $14.19▲ -0.3%Sep 3, 2026 · ThinkSabio Blog

$CRVS - Corvus Pharmaceuticals to Present at the 2026 Cantor Global Healthcare Conference…

News

CRVS ▼ -0.6% - Corvus Pharmaceuticals, Inc.

CP 14.64▲ -0.6%Aug 27, 2026 · ThinkSabio Blog

$CRVS - Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1b T Cell Lymphoma Trial…

SEC 13D/G

CRVS - Corvus Pharmaceuticals, Inc. - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks Simplified

$13.39▲ 82.92%Aug 7, 2026 · ThinkSabio Blog

$CRVS SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #CRVS Corvus Pharmaceuticals, Inc. : $13.39 Sector: Healthcare |…

SEC 13D/G

$CRVS SEC Filing Update (27-JUL-2026) | ThinkSabio - Stocks Simplified

$13.01▲ 77.73%Jul 27, 2026 · ThinkSabio Blog

$CRVS SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #CRVS : $13.01 Sector: Healthcare | YTD: 🔼+ 77.73% The SEC discl…